Abstract
MPM is a highly aggressive pleural tumor associated with asbestos exposure and with limited survival despite systemic therapy. Recently immunotherapy have demonstrated survival benefit. Studies of familial aggregation of MPM have identified BAP-1 as a tumour suppressor gene involved in the increased risk of mesothelioma. The objective of this study is to explore familial history of cancer in p diagnosed with MPM at our institution.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call